尼莫地平联合依达拉奉治疗脑出血后缺血性脑损害的临床疗效  

Clinical effect of nimodipine combined with edaravone in the treatment of ischemic brain damage after cerebral hemorrhage

作　　者：黄立[1] 龚细礼[1] Huang Li;Gong Xili(Department of Neurology,Xiangdong Hospital Affiliated to Hunan Normal University,Hunan Liling 412200)

机构地区：[1]湖南师范大学附属湘东医院神经内科,湖南醴陵412200

出　　处：《中国社区医师》2020年第20期54-55,共2页Chinese Community Doctors

摘　　要：目的:探究尼莫地平联合依达拉奉治疗脑出血后缺血性脑损害的临床效果。方法:2017年9月-2019年9月收治脑出血后缺血性脑损害患者86例,随机分为两组,各43例。试验组采用尼莫地平联合依达拉奉治疗;对照组采用依达拉奉治疗。比较两组临床效果。结果:试验组治疗后日常生活能力及神经功能缺损评分均显著优于对照组,治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论:应用尼莫地平联合依达拉奉治疗脑出血后缺血性脑损害,有利于提升患者日常生活能力,改善神经功能缺损情况,优化疗效。Objective:To explore the clinical effect of nimodipine combined with edaravone in the treatment of ischemic brain damage after cerebral hemorrhage.Methods:From September 2017 to September 2019,86 patients with ischemic brain damage after cerebral hemorrhage were selected,and they were randomly divided into two groups of 43 cases in each.The experimental group was treated with nimodipine and edaravone.The control group was treated with edaravone.We compared the clinical effects of the two groups.Results:In the experimental group,after treatment,the scores of ADL and neurological deficit were significantly better than those in the control group,and the total effective rate was higher than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Nimodipine combined with edaravone in the treatment of ischemic brain damage after intracerebral hemorrhage is conducive to improving the ability of daily life of patients,improving the condition of neurological deficit and optimizing the curative effect.

关 键 词：脑出血 缺血性脑损害 尼莫地平 依达拉奉 

分 类 号：R743.34[医药卫生—神经病学与精神病学]